A patient with confirmed myocardial ischemia and heart failure is being managed with beta-blockers and diuretics. The nurse is preparing to administer these medications. Which assessment finding should prompt the nurse to withhold the beta-blocker and notify the healthcare provider?

A) Heart rate of 58 beats per minute

B) Blood pressure of 140/90 mmHg

C) Bilateral crackles in the lung bases

A patient with a history of chronic hypertension presents with symptoms consistent with worsening cardiovascular function, including chest pain radiating to the left arm, shortness of breath, bilateral pitting edema, and elevated jugular venous pressure. The ECG shows ST-segment depression, and laboratory tests reveal elevated troponin and BNP levels. Which nursing intervention should be prioritized to address the patient's acute condition?

B) Initiate oxygen therapy to improve myocardial oxygenation.

A) Administer a stat dose of aspirin to reduce platelet aggregation.

B) Initiate oxygen therapy to improve myocardial oxygenation.

C) Prepare the patient for a stress test to determine exercise tolerance.

D) Encourage the patient to ambulate to prevent deep vein thrombosis.

A patient with significant coronary artery stenosis is being treated with beta-blockers and diuretics. Despite initial improvements, the patient still experiences episodes of chest discomfort and frequent premature ventricular contractions (PVCs). What is the most appropriate nursing action to prioritize at this time?

B) Notify the cardiology team for potential urgent intervention.

A) Administer supplemental oxygen to improve oxygen saturation.

B) Notify the cardiology team for potential urgent intervention.

C) Encourage the patient to perform deep breathing exercises to reduce anxiety.

D) Increase the dose of diuretics to address pulmonary congestion.

A patient with significant coronary artery stenosis is being treated for heart failure and is experiencing episodes of chest discomfort with frequent premature ventricular contractions (PVCs) noted on ECG. Which nursing intervention is most appropriate to prioritize while awaiting further cardiology evaluation?

B) Administer supplemental oxygen to improve myocardial oxygenation.

A) Encourage the patient to ambulate to prevent deep vein thrombosis.

B) Administer supplemental oxygen to improve myocardial oxygenation.

C) Increase the dose of diuretics to further reduce fluid overload.

D) Educate the patient on dietary modifications to reduce sodium intake.

A patient who recently underwent percutaneous coronary intervention (PCI) for significant stenosis in the left anterior descending artery is now experiencing mild dizziness and occasional palpitations. The ECG shows atrial fibrillation with a controlled ventricular response. What should be the nurse's priority action in managing this new development?

B) Administer a beta-blocker as prescribed to control heart rate.

A) Increase the patient's fluid intake to manage dizziness.

B) Administer a beta-blocker as prescribed to control heart rate.

C) Educate the patient on recognizing signs of thromboembolism.

D) Monitor the patient's neurological status for any changes.

A patient who recently underwent a percutaneous coronary intervention (PCI) for coronary artery disease is now experiencing mild dizziness and palpitations and has been diagnosed with atrial fibrillation. Which nursing intervention is most appropriate to prioritize in this patient's care plan to prevent complications?

B) Administer prescribed anticoagulation therapy and monitor for signs of bleeding

A) Encourage increased fluid intake to prevent dehydration

B) Administer prescribed anticoagulation therapy and monitor for signs of bleeding

C) Advise the patient to limit physical activity to reduce cardiac workload

D) Educate the patient on the importance of a low-sodium diet

A patient with a history of heart failure and newly diagnosed atrial fibrillation presents with increased respiratory rate, mild crackles on auscultation, and an elevated BNP level. The cardiology team adjusts the diuretic regimen. What nursing intervention is most important to implement to monitor the effectiveness of these changes?

B) Measure the patient's weight daily.

A) Assess the patient's capillary refill time every shift.

B) Measure the patient's weight daily.

C) Monitor the patient's blood glucose levels daily.

D) Check the patient's pedal pulses every 4 hours.

A nurse is caring for a patient with new onset atrial fibrillation and signs of fluid overload following a recent PCI. The patient's BNP level is elevated, and mild pulmonary congestion is noted on the chest X-ray. Which nursing action is the most appropriate to prioritize in this situation?

B) Administer the prescribed diuretic and monitor the patient's electrolyte levels closely.

A) Increase the patient's fluid intake to prevent dehydration.

B) Administer the prescribed diuretic and monitor the patient's electrolyte levels closely.

C) Encourage the patient to ambulate frequently to improve circulation.

D) Teach the patient techniques to reduce stress and anxiety, which may trigger arrhythmias.

A patient with heart failure and atrial fibrillation has been on adjusted diuretic therapy, and recent labs show a serum potassium level of 3.2 mmol/L and a magnesium level of 1.6 mg/dL. Which nursing intervention is the priority to prevent potential complications?

B) Administer prescribed potassium and magnesium supplements and monitor cardiac rhythm.

A) Educate the patient on dietary potassium sources to naturally increase potassium levels.

B) Administer prescribed potassium and magnesium supplements and monitor cardiac rhythm.

C) Increase the frequency of respiratory assessments to monitor for fluid overload.

D) Collaborate with the dietitian to create a low-sodium diet plan to support fluid management.

Heart disease - Nursing Case Study

Pathophysiology

• Primary mechanism: Atherosclerosis, the buildup of plaque in the coronary arteries, narrows these vessels and restricts blood flow. This can lead to ischemia, where heart muscle receives insufficient oxygen, increasing the risk of angina and myocardial infarction.

• Secondary mechanism: Hypertension exerts excessive pressure on the arterial walls, damaging the endothelium and accelerating plaque formation. This increases the heart's workload, potentially leading to left ventricular hypertrophy and heart failure.

• Key complication: The combination of atherosclerosis and hypertension can result in heart failure. The heart's ability to pump effectively is compromised, leading to fluid accumulation and symptoms like edema and dyspnea, significantly impacting a patient's quality of life.

Patient Profile

Demographics:

57-year-old male, office administrator

History:

• Key past medical history: Hypertension for 10 years, Type 2 Diabetes for 5 years, Family history of heart disease

• Current medications: Lisinopril, Metformin, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Chest pain and shortness of breath

• Key symptoms: Fatigue, occasional dizziness, palpitations, swelling in the ankles

• Vital signs: Blood pressure 150/95 mmHg, Heart rate 105 bpm, Respiratory rate 22 breaths per minute, Temperature 98.6°F, Oxygen saturation 92% on room air

Section 1

As the medical team conducts the initial assessment, they note that the patient's presentation is consistent with worsening cardiovascular function. The chest pain, described as a squeezing sensation that radiates to the left arm, alongside shortness of breath, suggests potential ischemic cardiac events. On physical examination, there is notable bilateral pitting edema in the ankles, indicating fluid retention. The jugular venous pressure is elevated, suggesting possible right-sided heart failure. Auscultation of the lungs reveals crackles at the bases, consistent with pulmonary congestion. These findings are indicative of a heart under stress, likely due to compromised coronary perfusion and increased systemic vascular resistance from poorly controlled hypertension.

Laboratory tests and imaging are ordered to gain further insight into the patient's condition. The ECG shows ST-segment depression, suggestive of myocardial ischemia. Blood work reveals elevated troponin levels, confirming myocardial injury, while brain natriuretic peptide (BNP) levels are significantly elevated, supporting the diagnosis of heart failure. The echocardiogram reveals reduced ejection fraction, indicative of systolic dysfunction, and left ventricular hypertrophy, a consequence of chronic hypertension. The coronary angiogram highlights significant stenosis in the left anterior descending artery, underscoring the severity of atherosclerotic disease.

Considering these findings, the clinical team discusses the need for immediate interventions to stabilize the patient's condition and prevent further deterioration. The initiation of beta-blockers and diuretics is considered to manage heart rate, reduce myocardial oxygen demand, and alleviate congestion. Given the critical nature of the coronary artery stenosis, a consultation with cardiology for potential revascularization procedures such as percutaneous coronary intervention (PCI) is prioritized. The patient's management plan will need to address both the acute ischemic and heart failure components while reassessing long-term strategies for managing his underlying chronic conditions.

Section 2

Following the initial interventions, the medical team closely monitors the patient's response to treatment. The administration of beta-blockers has successfully reduced the patient's heart rate to the target range, helping to decrease myocardial oxygen demand. The diuretics have started to alleviate some of the fluid overload, as evidenced by a reduction in pitting edema and slight improvement in jugular venous distension. However, the patient continues to experience episodes of chest discomfort, albeit less severe, prompting further evaluation of his condition.

Repeat laboratory tests reveal that while troponin levels are slightly decreasing, indicating stabilization of myocardial injury, the BNP levels remain elevated, suggesting persistent cardiac strain. Vital signs show a blood pressure of 142/88 mmHg, heart rate of 74 beats per minute, respiratory rate of 20 breaths per minute, and oxygen saturation of 94% on room air. Despite some progress with fluid management, the patient's lung auscultation still reveals bilateral crackles, indicating ongoing pulmonary congestion.

The clinical team considers the possibility of new complications. Given the patient's persistent symptoms and significant coronary artery stenosis, there is a concern for potential progression to acute coronary syndrome or the development of arrhythmias due to myocardial irritability. A repeat ECG is ordered, which shows frequent premature ventricular contractions that could indicate electrical instability. This new finding necessitates immediate attention to prevent arrhythmogenic events. The cardiology team is consulted urgently to reassess the need for more aggressive interventions, such as PCI, to address the critical coronary stenosis and improve coronary perfusion, which could mitigate the risk of further cardiac complications.

Section 3

The cardiology team decides to proceed with a coronary angiography to further evaluate the extent of coronary artery disease and determine the appropriate intervention. The results confirm significant stenosis in the left anterior descending artery, with additional moderate blockages in the right coronary artery. Given the critical nature of the findings, the decision is made to proceed with percutaneous coronary intervention (PCI) to restore adequate blood flow and reduce myocardial oxygen demand.

Following the PCI, the patient's vital signs are closely monitored. Blood pressure stabilizes at 130/85 mmHg, and the heart rate remains steady at 72 beats per minute. Oxygen saturation improves to 96% on room air, and there is a noticeable reduction in respiratory distress, as evidenced by lessened bilateral crackles upon auscultation. The patient reports a significant decrease in chest discomfort, and repeat laboratory tests show a further decline in troponin levels, suggesting resolution of myocardial ischemia.

Despite these improvements, the patient begins to experience mild dizziness and occasional palpitations. A repeat ECG indicates the presence of atrial fibrillation with a controlled ventricular response. This new arrhythmia, likely precipitated by the myocardial stress and recent intervention, requires careful consideration. The clinical team initiates anticoagulation therapy to prevent thromboembolic events and discusses the potential need for rate or rhythm control strategies. This development prompts further evaluation and adjustment of the patient's treatment plan, emphasizing the importance of ongoing monitoring and tailored management to address the evolving clinical picture.

Section 4

As the clinical team addresses the patient's new onset atrial fibrillation, they continue to monitor for any additional complications. During a routine assessment, the nurse notes that the patient appears slightly more diaphoretic and expresses mild fatigue, symptoms that warrant further investigation. Vital signs remain largely stable with a blood pressure of 128/80 mmHg and a heart rate controlled at 78 beats per minute under medical management. However, the nurse observes that the patient's respiratory rate has increased to 22 breaths per minute, and there is a subtle return of mild bilateral crackles upon auscultation, suggesting a potential shift in fluid status.

To further evaluate the patient's condition, the team orders a repeat chest X-ray and additional laboratory tests, including a B-type natriuretic peptide (BNP) level. The chest X-ray reveals mild pulmonary congestion, raising concerns about fluid overload or heart failure exacerbation. The BNP level is elevated at 450 pg/mL, indicating increased ventricular strain. These findings suggest that while the PCI had initially stabilized the patient, the new atrial fibrillation and potential fluid retention are contributing to a resurgence of heart failure symptoms.

In response to these developments, the cardiology team decides to adjust the patient's diuretic regimen to better manage fluid balance and prevent further cardiac decompensation. They also contemplate the need for potential rate control adjustments or further rhythm management strategies to mitigate the effects of atrial fibrillation on cardiac output. This situation underscores the necessity for continuous reassessment and dynamic treatment planning, highlighting the intricate interplay between cardiac interventions, rhythm disturbances, and heart failure management. The focus remains on optimizing the patient's hemodynamic status while minimizing the risk of further complications.

Section 5

Following the adjustments to the diuretic regimen, the team closely monitors the patient's response to the intervention. Over the next 24 hours, the patient exhibits a slight improvement in respiratory status, with the respiratory rate decreasing to 20 breaths per minute and a reduction in the crackles heard on auscultation. However, the patient still reports intermittent episodes of dyspnea on exertion and continues to feel fatigued, suggesting that while the fluid management strategy is having a positive impact, there may be additional factors contributing to the persistent symptoms.

A repeat set of laboratory tests is conducted, revealing that the patient's electrolyte levels have been affected by the increased diuresis. The serum potassium level has dropped to 3.2 mmol/L, and the magnesium level is slightly reduced at 1.6 mg/dL. These findings prompt the healthcare team to initiate electrolyte replacement therapy to prevent potential complications such as arrhythmias, which could be exacerbated by the patient's existing atrial fibrillation. Additionally, the patient's renal function is closely monitored, as the blood urea nitrogen (BUN) and creatinine levels are slightly elevated, indicating a need to balance diuretic therapy with renal perfusion.

Despite these challenges, the patient's overall hemodynamic status remains stable, with a blood pressure of 126/78 mmHg and a heart rate maintaining at 75 beats per minute under controlled medication. The cardiology team considers the possibility of introducing or adjusting anti-arrhythmic medications to further stabilize the heart rhythm and improve cardiac output. The focus remains on fine-tuning the therapeutic approach to address both the heart failure symptoms and the atrial fibrillation, ensuring that the patient's condition continues to advance towards stabilization without the onset of further complications. This stage of the patient's care journey emphasizes the importance of a multidisciplinary approach and vigilant monitoring to adapt treatment plans based on the evolving clinical picture.